Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Kidd

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Therapeutics|January 2, 2018
Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site AdministrationJames M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2019
In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faeciumMichael P Lorenzo, James M Kidd, Stephen G Jenkins, et al.
Clinical Therapeutics|October 20, 2018
Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261-269]James M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2019
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary ExacerbationJames M Kidd, Colleen M Sakon, Louise-Marie Oleksiuk, et al.
Surgical Infections|October 24, 2018
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill PatientsGary E Stein, Curtis L Smith, Amy Scharmen, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Therapeutics|January 2, 2018
Physical Compatibility of Meropenem and Vaborbactam With Select Intravenous Drugs During Simulated Y-site AdministrationJames M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
The Journal of Antimicrobial Chemotherapy|May 4, 2019
In vitro activity of ampicillin and ceftriaxone against ampicillin-susceptible Enterococcus faeciumMichael P Lorenzo, James M Kidd, Stephen G Jenkins, et al.
Clinical Therapeutics|October 20, 2018
Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261-269]James M Kidd, Lindsay M Avery, Tomefa E Asempa, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2019
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary ExacerbationJames M Kidd, Colleen M Sakon, Louise-Marie Oleksiuk, et al.
Surgical Infections|October 24, 2018
Pharmacokinetic and Pharmacodynamic Analysis of Ceftazidime/Avibactam in Critically Ill PatientsGary E Stein, Curtis L Smith, Amy Scharmen, et al.
Pageof 2